Sotio Starts Phase 1/2 Trial of DCVAC/PCa plus ONCOS-102 in Advanced Prostate Cancer
News
The first patient has enrolled in Sotio‘s Phase 1/2 clinical trial testing the immunotherapy DCVAC/PCa in combination with ONCOS-102 in men with advanced prostate cancer. The patient was enrolled in Prague, ... Read more